logo

Crowdly

Browser

Add to Chrome

BMS3031 - Molecular mechanisms of disease - S1 2026

Looking for BMS3031 - Molecular mechanisms of disease - S1 2026 test answers and solutions? Browse our comprehensive collection of verified answers for BMS3031 - Molecular mechanisms of disease - S1 2026 at learning.monash.edu.

Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!

A melanoma patient with a B-RAF(V600E)

tumour initially responds well to the BRAF inhibitor vemurafenib, but the

tumour later resumes rapid growth. Genetic analysis reveals the presence of a

p61 B-RAF(V600E) splice variant that lacks part of the regulatory region of the

protein.

Which mechanism best explains why this

variant confers resistance to vemurafenib?

100%
0%
0%
0%
View this question

After exposing cells to UV radiation,

a researcher sequences several regions of DNA and notices that mutations

frequently occur at sites where two pyrimidine bases occur next to each other

on the same DNA strand. These sites correspond to where cyclobutane pyrimidine

dimers are most likely to form.

Which of the following sequences would

therefore be most vulnerable to UV-induced DNA damage?

0%
0%
0%
100%
View this question

During a skin examination, a

dermatologist explains that dysplastic nevi are monitored carefully because

they can sometimes represent early stages of melanoma development.

Why are individuals with many dysplastic nevi

considered at higher risk of melanoma?

0%
100%
0%
0%
View this question

Researchers are investigating

malignant cells that proliferate independently of normal growth constraints.

Detailed molecular profiling identifies multiple alterations affecting

signalling pathways and gene regulation.

Which modification most directly promotes

sustained pro-proliferative signalling in these cancer cells?

100%
0%
0%
0%
View this question

A researcher is studying a solid

tumour in a preclinical model. Genetic or pharmacologic interventions have

blocked angiogenesis, preventing the tumour from forming new blood vessels. The

tumour remains viable but shows changes in its growth and behaviour compared to

untreated controls.

Which aspect of tumourigenesis is most

directly limited by the absence of angiogenesis?

0%
0%
0%
100%
View this question

A researcher observes a population of

cells in a tissue sample showing abnormal cell division and clonal expansion.

However, there is no evidence of epigenetic alteration or genomic instability.

Which explanation best accounts for

the observed clonal expansion?

0%
100%
0%
0%
View this question

A patient with metastatic melanoma is

treated with an antibody which blocks the immune checkpoint inhibitor PD-1.

Post-treatment blood analysis shows that cytotoxic T cells exhibit increased

metabolic activity, proliferation, and effector function. Molecular assays

indicate that intracellular PI3K/mTOR and RAS/MAPK pathways in these T cells

are activated.

Which explanation best accounts for

the enhanced anti-tumor immune response?

0%
0%
100%
0%
View this question

A new monoclonal antibody directed to

a tumour antigen is tested against a panel of tumour cells in the presence or

absence of innate immune cells. Tumour cell death occurs only when innate

immune cells expressing Fc gamma receptor III (CD16) are present. In contrast,

chemical inhibition of the complement cascade has no effect on tumour killing.

Which mechanism most likely explains

how this antibody mediates tumour cell death?

0%
100%
0%
0%
View this question

In a lab model of HER2-positive breast

cancer, cells are treated with trastuzumab. Initially, most cells are killed,

but a subset survives and continues proliferating. Sequencing and protein analysis

reveal that the HER2 receptor lacks the extracellular domain required for

trastuzumab binding, though downstream signalling remains active.

Which explanation best accounts for

this resistance?

0%
100%
0%
0%
View this question

A patient with an aggressive lymphoma

is prescribed a combination of two chemotherapeutic agents. Laboratory studies

show that some cancer cells are resistant to the first drug, while others are

sensitive. The combination therapy results in a much higher overall rate of

cancer cell death compared to either drug alone.

Which explanation best accounts for

the rationale behind using combination chemotherapy in this context?

100%
0%
0%
0%
View this question

Want instant access to all verified answers on learning.monash.edu?

Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!

Browser

Add to Chrome